Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,367 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Completed

Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma

NCT03422536

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +41 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

NCT03693612

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +33 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT01064479

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson Regional Care Center-Katy Houston, Texas, United States
  • MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
  • MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

NCT02383927

Conditions
Carcinoma, Carcinoma, Squamous Cell, Endocrine Gland Neoplasms, +13 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Wihship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 35 locations
View Trial Details
Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Completed

A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors

NCT05538572

Conditions
Adenoma, Astrocytoma, Breast Cancer, +43 more
Locations
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Celebration, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 13 locations
View Trial Details
Completed

Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid

NCT05578820

Conditions
Anus Diseases, Anus Neoplasms, Breast Diseases, +47 more
Locations
  • GBUZ Moscow Clinical Scientific Center named after Loginov MHD Moscow, Russia
  • FSBI N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia Moscow, Russia
  • FSBI National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I.Kulakov of the Ministry of Health of Russia Moscow, Russia
  • National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation Moscow, Russia
View Trial Details

Related conditions